Table I.
Group 1 (cocaine) |
Group 2 (other drugs) |
Group 3 (controls) |
P | |
---|---|---|---|---|
| ||||
At birth | ||||
Sample size (n) | 95 | 110 | 97 | |
Male (%) | 46 | 60 | 50 | .11 |
Gestational age (weeks) | 38.4 ± 1.9 | 39.0 ± 1.6 | 39.4 ± 1.2 | .0001*† |
Weight (kg) | 2.9 ± 5.0 | 3.1 ± 4.9 | 3.2 ± 4.2 | .0001*† |
Length (cm) | 48.2 ± 2.8 | 49.6 ± 2.6 | 49.8 ± 2.2 | .0001*† |
Head circumference (cm) | 33.3 ± 1.5 | 33.9 ± 1.6 | 34.2 ± 1.4 | .0001*† |
White (%) | 31 | 38 | 21 | .02‡ |
At follow up | ||||
Sample size (n) | 71 | 89 | 77 | |
Age (months) | 2.8 ± 2.1 | 2.3 ± 1.0 | 2.5 ± 2.6 | .19 |
Body surface area (m2) | 0.20 ± 0.03 | 0.21 ± 0.03 | 0.21 ± 0.03 | .26 |
Cocaine versus controls at birth.
Cocaine versus other drugs at birth.
Other drugs versus no drugs at birth.